Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-023670
Filing Date
2025-09-04
Accepted
2025-09-04 16:27:49
Documents
1
Period of Report
2025-09-02

Document Format Files

Seq Description Document Type Size
1 form4-09042025_080945.html 4  
1 form4-09042025_080945.xml 4 7798
  Complete submission text file 0001415889-25-023670.txt   9327
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Issuer) CIK: 0001653087 (see all company filings)

EIN.: 822933343 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ALECTOR, INC. 151 OYSTER POINT BLVD., #300 SOUTH SAN FRANCISCO CA 94080
Business Address
Rosenthal Arnon (Reporting) CIK: 0001757770 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38792 | Film No.: 251293779